# Clinical Trial Landscape: 11_young_sarcoma_treatment_naive

*Generated: 2026-01-05 06:59:52*

## Summary

- **Total Trials**: 62
- **Flagged for Review**: 0
- **Search Terms Used**: 11

## Phase Distribution

| Phase | Count | Distribution |
|-------|-------|--------------|
| Phase 3 | 17 | █████ 27.4% |
| Phase 1 | 15 | ████ 24.2% |
| Not Applicable | 10 | ███ 16.1% |
| Unknown | 6 | █ 9.7% |
| Phase 2 | 5 | █ 8.1% |
| Phase 1/Phase 2 | 5 | █ 8.1% |
| Phase 2/Phase 3 | 3 |  4.8% |
| Early Phase 1 | 1 |  1.6% |

## Status Distribution

- **Recruiting**: 56 (90.3%)
- **Not yet recruiting**: 5 (8.1%)
- **Enrolling by invitation**: 1 (1.6%)

## Top Sponsors

| Sponsor | Trial Count |
|---------|-------------|
| Eli Lilly and Company | 3 |
| Sanofi | 3 |
| National Cancer Institute (NCI) | 2 |
| Janssen Research & Development, LLC | 2 |
| Takeda | 2 |
| The University of Texas Health Science Center at S | 2 |
| Merck Sharp & Dohme LLC | 2 |
| University of Michigan | 1 |
| Stanford University | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Harpoon Therapeutics, Inc., a subsidiary of Merck  | 1 |
| Pfizer | 1 |
| Baylor College of Medicine | 1 |
| Children's Hospital Los Angeles | 1 |
| BeiGene | 1 |

## Interventions

| Intervention | Occurrences |
|--------------|-------------|
| Placebo | 12 |
| Cyclophosphamide | 3 |
| Blood Draw | 2 |
| Rituximab | 2 |
| Biospecimen Collection | 2 |
| Computed Tomography | 2 |
| Magnetic Resonance Imaging | 2 |
| Elotuzumab | 2 |
| Pomalidomide | 2 |
| Dexamethasone | 2 |
| Riliprubart | 2 |
| riliprubart | 2 |
| IVIg | 2 |
| DNTH103 | 2 |
| CPAP | 1 |
| Mogamulizumab | 1 |
| LD TSEBT | 1 |
| Trapeziectomy with ligament reconstruction (I; LRT | 1 |
| Trapeziectomy with suture suspensionplasty (II; SS | 1 |
| Arthroscopic Trapeziectomy (III; AT) | 1 |

## Geographic Distribution

| Country | Trial Count |
|---------|-------------|
| United States | 62 |
| Germany | 16 |
| Italy | 15 |
| Japan | 14 |
| France | 13 |
| Poland | 13 |
| Spain | 13 |
| China | 11 |
| Belgium | 11 |
| United Kingdom | 11 |
| Netherlands | 11 |
| South Korea | 10 |
| Canada | 10 |
| Czechia | 10 |
| Argentina | 9 |

## Search Term Provenance

| Term | Source | Confidence |
|------|--------|------------|
| SS18-SSX fusion | manual | 1.0 |
| SS18-SSXfusion | manual | 0.9 |
| SS18-SSX-fusion | manual | 0.9 |
| synovial sarcoma | manual | 1.0 |
| SS18-SSX fusion synovial sarcoma | manual | 1.0 |
| SS18-SSX fusion synovial sarcoma (SS18-SSX1) | llm | 0.9 |
| synovial sarcoma with SS18-SSX fusion | llm | 0.9 |
| SS | llm | 0.8 |
| synovial soft tissue sarcoma | llm | 0.8 |
| SS18-SSX1 | llm | 0.9 |
| SS18-SSX | llm | 0.9 |

## All Trials

| NCT ID | Phase | Status | Sponsor | Title |
|--------|-------|--------|---------|-------|
| [NCT07261657](https://clinicaltrials.gov/study/NCT07261657) | Early Phase 1 | Not yet recruiting | Northwestern Univers... | A Pilot Trial of N-803 in Patients ... |
| [NCT06713473](https://clinicaltrials.gov/study/NCT06713473) | Not Applicable | Not yet recruiting | Florida State Univer... | Reducing Self-Dehumanization to Exa... |
| [NCT06799702](https://clinicaltrials.gov/study/NCT06799702) | Not Applicable | Not yet recruiting | University of Georgi... | Trauma-informed, Resilience-based T... |
| [NCT07286383](https://clinicaltrials.gov/study/NCT07286383) | Phase 3 | Not yet recruiting | VA Office of Researc... | Testing the Use of VA Peer Speciali... |
| [NCT06625190](https://clinicaltrials.gov/study/NCT06625190) | Phase 1/Phase 2 | Recruiting | University of Florid... | Allogeneic Stem Cell Transplantatio... |
| [NCT07282600](https://clinicaltrials.gov/study/NCT07282600) | Phase 3 | Recruiting | Eli Lilly and Compan... | A Phase 3 Randomized, Double-Blind,... |
| [NCT07225296](https://clinicaltrials.gov/study/NCT07225296) | Phase 1 | Recruiting | Genosco Inc. | A Randomized, Double-blind, Placebo... |
| [NCT07221240](https://clinicaltrials.gov/study/NCT07221240) | Phase 1 | Recruiting | PRG Science & Techno... | A Phase 1, Randomized, Double-blind... |
| [NCT06920004](https://clinicaltrials.gov/study/NCT06920004) | Phase 3 | Recruiting | argenx | A Phase 3, Randomized, Double-Blind... |
| [NCT06946225](https://clinicaltrials.gov/study/NCT06946225) | Phase 1 | Recruiting | Immatics US, Inc. | A First-in-human, Open-label Trial ... |
| [NCT07032272](https://clinicaltrials.gov/study/NCT07032272) | Phase 1 | Recruiting | Novartis Pharmaceuti... | A Phase 1, Open-label Study to Inve... |
| [NCT07064473](https://clinicaltrials.gov/study/NCT07064473) | Phase 3 | Recruiting | Boehringer Ingelheim | A Phase III Double-blind, Randomise... |
| [NCT06900712](https://clinicaltrials.gov/study/NCT06900712) | Not Applicable | Recruiting | Case Western Reserve... | A Novel, Single-Session Interventio... |
| [NCT06748872](https://clinicaltrials.gov/study/NCT06748872) | Phase 1 | Not yet recruiting | Medigene AG | EPITOME-1015-I: a Phase I Study to ... |
| [NCT06832618](https://clinicaltrials.gov/study/NCT06832618) | Phase 3 | Recruiting | Incyte Corporation | A Phase 3b, Double-Blind, Multicent... |
| [NCT06689891](https://clinicaltrials.gov/study/NCT06689891) | Not Applicable | Recruiting | Yale University | Utilizing Remote, Video-Based Pelvi... |
| [NCT06795659](https://clinicaltrials.gov/study/NCT06795659) | Phase 1/Phase 2 | Recruiting | The University of Te... | Combining Esketamine and Prolonged ... |
| [NCT06736171](https://clinicaltrials.gov/study/NCT06736171) | Not Applicable | Recruiting | Kessler Foundation | Prescription of Robotic Exoskeleton... |
| [NCT06972459](https://clinicaltrials.gov/study/NCT06972459) | Phase 3 | Recruiting | Eli Lilly and Compan... | A Master Protocol to Investigate th... |
| [NCT06747351](https://clinicaltrials.gov/study/NCT06747351) | Phase 3 | Recruiting | Takeda | A Phase 3, Single-Arm, Multiple-Dos... |
| [NCT06970301](https://clinicaltrials.gov/study/NCT06970301) | Phase 1 | Recruiting | UCB Biopharma SRL | A Single-center, Placebo-controlled... |
| [NCT06890884](https://clinicaltrials.gov/study/NCT06890884) | Phase 2 | Recruiting | Merck Sharp & Dohme ... | A Randomized, Open-label, Multicent... |
| [NCT06859099](https://clinicaltrials.gov/study/NCT06859099) | Phase 3 | Enrolling by invitation | Sanofi | Long-term Extension Study to Evalua... |
| [NCT06858579](https://clinicaltrials.gov/study/NCT06858579) | Phase 3 | Recruiting | Dianthus Therapeutic... | A Phase 3 Randomized, Double-Blind,... |
| [NCT06752668](https://clinicaltrials.gov/study/NCT06752668) | Phase 2 | Recruiting | Centessa Pharmaceuti... | A Phase 2a, Randomized, Double-blin... |
| [NCT06644755](https://clinicaltrials.gov/study/NCT06644755) | Phase 1 | Recruiting | Daiichi Sankyo | Phase 1, Open-Label, Multicenter, F... |
| [NCT05582993](https://clinicaltrials.gov/study/NCT05582993) | Phase 3 | Recruiting | Takeda | A Phase 3, Prospective, Open-label,... |
| [NCT06727097](https://clinicaltrials.gov/study/NCT06727097) | N/A | Recruiting | University of Cincin... | Tracking the Development and Influe... |
| [NCT06447168](https://clinicaltrials.gov/study/NCT06447168) | N/A | Recruiting | Ipsen | Prospective Non-interventional, Pha... |
| [NCT06290141](https://clinicaltrials.gov/study/NCT06290141) | Phase 3 | Recruiting | Sanofi | A Phase 3, Randomized, Double-blind... |
| [NCT06524635](https://clinicaltrials.gov/study/NCT06524635) | Phase 2 | Recruiting | AbbVie | A Multicenter Open-Label Interventi... |
| [NCT06216301](https://clinicaltrials.gov/study/NCT06216301) | Phase 3 | Recruiting | NovoCure GmbH | LUNAR-2: Pivotal, Randomized, Open-... |
| [NCT06096597](https://clinicaltrials.gov/study/NCT06096597) | Phase 2/Phase 3 | Recruiting | David Sheyn | Amniotic Membrane Therapy for Inter... |
| [NCT06290128](https://clinicaltrials.gov/study/NCT06290128) | Phase 3 | Recruiting | Sanofi | A Phase 3, Double-blind, Placebo-co... |
| [NCT06351631](https://clinicaltrials.gov/study/NCT06351631) | Phase 3 | Recruiting | Merck Sharp & Dohme ... | A Multicenter, Open-Label, Extensio... |
| [NCT06083883](https://clinicaltrials.gov/study/NCT06083883) | Phase 1 | Recruiting | M.D. Anderson Cancer... | Phase I/Ib Study of Adoptive NK Exp... |
| [NCT06225804](https://clinicaltrials.gov/study/NCT06225804) | Phase 1 | Recruiting | Abbisko Therapeutics... | A Phase 1, Open-Label Study of ABSK... |
| [NCT05711615](https://clinicaltrials.gov/study/NCT05711615) | Phase 1 | Recruiting | National Cancer Inst... | A Phase 1 Study of Peposertib (M381... |
| [NCT06208150](https://clinicaltrials.gov/study/NCT06208150) | Phase 3 | Recruiting | Janssen Research & D... | A Phase 3 Randomized Study Comparin... |
| [NCT06187402](https://clinicaltrials.gov/study/NCT06187402) | Phase 1/Phase 2 | Recruiting | LaNova Medicines Lim... | A Phase I/II, First-in-Human (FIH),... |
| [NCT05730036](https://clinicaltrials.gov/study/NCT05730036) | Phase 3 | Recruiting | Regeneron Pharmaceut... | An Open-label, Randomized, Phase 3 ... |
| [NCT05642455](https://clinicaltrials.gov/study/NCT05642455) | Phase 1/Phase 2 | Recruiting | Adaptimmune | A Phase 1/2 Open Label, Basket Stud... |
| [NCT05910307](https://clinicaltrials.gov/study/NCT05910307) | N/A | Recruiting | Children's Hospital ... | Synovial Sarcoma Registry and Biosp... |
| [NCT05385965](https://clinicaltrials.gov/study/NCT05385965) | Not Applicable | Recruiting | Duke University | Meaning-Centered Pain Coping Skills... |
| [NCT05651945](https://clinicaltrials.gov/study/NCT05651945) | Not Applicable | Recruiting | Hackensack Meridian ... | Stroke Recovery Program-Cardiac Reh... |
| [NCT05696691](https://clinicaltrials.gov/study/NCT05696691) | Phase 2/Phase 3 | Recruiting | The University of Te... | A Randomized Pilot Trial of Intramu... |
| [NCT05661461](https://clinicaltrials.gov/study/NCT05661461) | Phase 1 | Recruiting | Aadi Bioscience, Inc... | A Phase 1, Open-label, Dose-escalat... |
| [NCT05965245](https://clinicaltrials.gov/study/NCT05965245) | Not Applicable | Recruiting | Washington Universit... | Suubi-Mhealth: A Mobile Health Inte... |
| [NCT05941039](https://clinicaltrials.gov/study/NCT05941039) | Not Applicable | Recruiting | Clarkson University | Effects of Vestibular Training on P... |
| [NCT05227326](https://clinicaltrials.gov/study/NCT05227326) | Phase 1 | Recruiting | City of Hope Medical... | First in Human Phase 1 Study of AOH... |

*... and 12 more trials (see trials.csv for full list)*
